Keenova Publishes New Real-World Acthar Gel Autoimmune Data
DUBLIN, Ireland, July 13, 2026 Keenova Therapeutics plc has announced the publication of a new peer-reviewed real-world evidence study...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
DUBLIN, Ireland, July 13, 2026 Keenova Therapeutics plc has announced the publication of a new peer-reviewed real-world evidence study...
FRANKLIN, Tenn., July 7, 2026 Kythera Labs has expanded its strategic partnership with Databricks by launching the Clinical Semantic...
PRINCETON, N.J., June 30, 2026 Kyowa Kirin has announced new clinical analyses demonstrating that mogamulizumab continues to deliver meaningful...
NEW YORK, June 30, 2026 Renalytix PLC has announced the publication of groundbreaking two-year real-world evidence (RWE) demonstrating that...
DUBLIN, Ireland, June 16, 2026 Jazz Pharmaceuticals plc has unveiled extensive late-breaking research at SLEEP 2026, presenting 11 new...
VANCOUVER, B.C. & GRAPEVine, Texas, June 9, 2026 Alpha Cognition Inc. announced positive top-line results from the BEACON Phase...
PARSIPPANY, New Jersey, USA & TEL AVIV, Israel – June 8, 2026 Teva Pharmaceuticals has unveiled new real-world and...
BERKELEY HEIGHTS, N.J., May 28, 2026 Tonix Pharmaceuticals presented new real-world data at the 2026 American Society of Clinical...
RALEIGH, N.C. | May 28, 2026 Parexel announced that two oncology-focused research posters have been accepted for presentation at...
PARSIPPANY, N.J. and TEL AVIV, Israel, May 18, 2026 Teva Pharmaceuticals has announced new findings from its ongoing IMPACT-TD...
